跳至主要内容
临床试验/NL-OMON21572
NL-OMON21572已完成不适用

Medical Nutrition in prodromal Alzheimer's Disease, a double-blind controlled 24-month study with four 12-month double-blind extension studies, followed by two 12-month open-label extension studies

The European LipiDiDiet Consortium0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
300

研究概览

简要总结

  • Soininen H, et al. Lancet Neurol. 2017;16:965-75 [PMID: 29097166] * Van Oudenhoven FM, et al. BMC Med Res Methodol. 2019;19:163 [PMID: 31345172] * Hendrix SB, et al. The Journal of Prevention of Alzheimer's Disease, 2019:1-5 [PMID: 31686094] * Soininen H, et al. Alzheimer's Dement. 2021;17:29-40 [PMID: 32920957] * Van Oudenhoven FM, et al. Alz Res Therapy. 2021;13:63 [PMID: 33752738] * Rosenberg A, et al. Alz Res Therapy. 2021;13:64 [PMID: 33766132]

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Prodromal AD as defined by episodic memory disorder and evidence for underlying AD pathology (Dubois et al 2007);
  • 2. Age 55 - 85 years;

排除标准

  • 1. Dementia according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV);
  • 2. Use of omega-3 preparations;

研究者

发起方
The European LipiDiDiet Consortium

相似试验